We are live on
!
Find out more
ICM
IMS Capital Management Portfolio holdings
AUM
$217M
1-Year Est. Return
18.69%
This Fund
S&P 500
This Quarter
Est. Return
+0.43%
1 Year Est. Return
+18.69%
3 Year Est. Return
+119.31%
5 Year Est. Return
+117.37%
10 Year Est. Return
+287.2%
AUM
$84.1M
AUM Growth
-$5.17M
(-5.8%)
Cap. Flow
-$4.63M
Cap. Flow
% of AUM
-5.51%
Top 10 Holdings %
Top 10 Hldgs %
22.33%
Holding
177
New
26
Increased
51
Reduced
46
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIV
InVivo Therapeutics Holdings Corp
NVIV
|
+$2.38M |
| 2 |
APA Corp
APA
|
+$1.13M |
| 3 |
American Express
AXP
|
+$914K |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$857K |
| 5 |
LNCO
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
|
+$850K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$887K |
| 2 |
Opko Health
OPK
|
+$813K |
| 3 |
Procter & Gamble
PG
|
+$739K |
| 4 |
Starbucks
SBUX
|
+$688K |
| 5 |
SUP
Superior Industries International
SUP
|
+$646K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.37% |
| 2 | Financials | 15.58% |
| 3 | Consumer Discretionary | 14.24% |
| 4 | Technology | 11.42% |
| 5 | Energy | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Noodles & Co
NDLS
$95.1M
| $970K | 1.15% |
8,305
+6,125
| +281% | +$830K |
|
27
Lincoln National
LNC
$7.92B
| $965K | 1.15% |
16,298
-2,267
| -12% | -$133K |
|
28
Amazon
AMZN
$2.44T
| $959K | 1.14% |
44,180
-29,500
| -40% | -$617K |
|
29
Alphabet (Google) Class C
GOOG
$4.11T
| $957K | 1.14% |
36,480
+28,799
| +375% | +$772K |
|
30
Occidental Petroleum
OXY
$55.7B
| $940K | 1.12% |
12,111
+742
| +7% | +$58K |
|
31
SLB Ltd
SLB
$72.7B
| $905K | 1.08% |
10,502
-1,389
| -12% | -$125K |
|
|
32
American Express
AXP
$224B
| $895K | 1.06% |
+11,515
| New | +$914K |
|
33
Bristol-Myers Squibb
BMY
$129B
| $893K | 1.06% |
13,422
-2,347
| -15% | -$155K |
|
34
Verizon
VZ
$197B
| $860K | 1.02% |
18,458
-11,476
| -38% | -$562K |
|
35
EOG Resources
EOG
$77.7B
| $845K | 1% |
9,650
-965
| -9% | -$89.2K |
|
36
VanEck IG Floating Rate ETF
FLTR
$2.94B
| $809K | 0.96% |
32,543
+6,122
| +23% | +$152K |
|
37
NOV
NOV
$6.84B
| $806K | 0.96% |
16,690
-2,010
| -11% | -$103K |
|
38
Zimmer Biomet
ZBH
$18.8B
| $796K | 0.95% |
7,506
+1
| +0% | +$111 |
|
|
YHOO
39
DELISTED
Yahoo Inc
YHOO
| $784K | 0.93% |
+19,954
| New | +$857K |
|
40
JPMorgan Chase
JPM
$916B
| $753K | 0.9% |
+11,115
| New | +$726K |
|
|
LNCO
41
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
| $719K | 0.86% |
+76,055
| New | +$850K |
|
42
Idexx Laboratories
IDXX
$44.9B
| $687K | 0.82% |
10,710
-2,800
| -21% | -$194K |
|
43
Johnson & Johnson
JNJ
$640B
| $680K | 0.81% |
6,976
+936
| +15% | +$93.7K |
|
44
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.05B
| $676K | 0.8% |
5,865
+1,229
| +27% | +$144K |
|
45
AbbVie
ABBV
$465B
| $653K | 0.78% |
9,725
+638
| +7% | +$41.7K |
|
46
Edwards Lifesciences
EW
$49.4B
| $632K | 0.75% |
26,640
-9,360
| -26% | -$211K |
|
47
WaFd
WAFD
$2.71B
| $624K | 0.74% |
26,712
-750
| -3% | -$16.8K |
|
48
iShares Russell Mid-Cap Growth ETF
IWP
$19.4B
| $622K | 0.74% |
12,846
+2,368
| +23% | +$117K |
|
49
Jabil
JBL
$30.1B
| $605K | 0.72% |
28,431
-15,000
| -35% | -$354K |
|
|
50
Opko Health
OPK
$1.02B
| $600K | 0.71% |
37,303
-52,260
| -58% | -$813K |
|
Similar funds
DSN
FFAM
MS
NWM
LA
SNWA
APC
WTFG
IMS Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, IMS Capital Management held 177 positions worth $84.1M, down 5.8% from $89.3M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
IMS Capital Management withdrew a net $4.63M in Q2 2015, closing 45 positions and reducing 46 holdings. Its most notable exit was Walmart Inc, an estimated $887K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, IMS Capital Management opened a new position in InVivo Therapeutics Holdings Corp worth $2.71M.
- IMS Capital Management's largest Q2 2015 buy was InVivo Therapeutics Holdings Corp: 9 shares worth $2.71M.
- IMS Capital Management added most to Noodles & Co in Q2 2015, an estimated $830K increase.
- IMS Capital Management's biggest Q2 2015 reduction was Opko Health, cutting an estimated $813K.
- IMS Capital Management fully exited Walmart Inc in Q2 2015, selling an estimated $887K.
- IMS Capital Management's ten largest holdings make up 22% of its $84.1M portfolio in Q2 2015.
- IMS Capital Management opened 26 new positions and closed 45 in Q2 2015.
- IMS Capital Management's portfolio value fell 5.8% quarter-over-quarter to $84.1M.
Based on IMS Capital Management's 13F filing for Q2 2015, filed 17 Jul 2015.